Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2018 16:01 ET | Source: IntelGenx Corp.

IntelGenx Reports Fourth Quarter and Full-Year 2017 Financial Results

SAINT LAURENT, Quebec, March 29, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter...
March 27, 2018 17:00 ET | Source: IntelGenx Corp.

IntelGenx Announces Update on Private Placement and Proposed LaboVal Acquisition

SAINT LAURENT, Quebec, March 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces that, due to market conditions, it will not...
March 23, 2018 16:01 ET | Source: IntelGenx Corp.

IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow

SAINT LAURENT, Quebec, March 23, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2017...
March 12, 2018 13:12 ET | Source: IntelGenx Corp.

IntelGenx Clarifies Recent Preliminary 2018 Proxy Statement Filing

SAINT LAURENT, Quebec, March 12, 2018 (GLOBE NEWSWIRE) -- In response to investor inquiries received about its preliminary proxy statement, filed with the U.S. Securities and Exchange Commission on...
January 26, 2018 16:00 ET | Source: IntelGenx Corp.

IntelGenx Mourns the Passing of long term Director Ian Troup

SAINT-LAURENT, Quebec, Jan. 26, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (“IntelGenx”), (TSXV:IGX) (OTCQX:IGXT) -- The Board of Directors of IntelGenx was advised today of the passing...
January 24, 2018 08:00 ET | Source: IntelGenx Corp.

IntelGenx Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients

SAINT-LAURENT, Quebec, Jan. 24, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that it has initiated the Phase 2a proof...
January 04, 2018 08:00 ET | Source: IntelGenx Corp.

IntelGenx To Present at Biotech Showcase(TM) 2018

SAINT-LAURENT, Quebec, Jan. 04, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") today announced that its President and Chief Executive Officer,...
December 18, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Site Obtains GMP Compliant Rating From Health Canada for Manufacturing and Packaging Activities

SAINT-LAURENT, QUEBEC--(Marketwired - Dec. 18, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that, following a Good...
December 15, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives Health Canada Clearance to Begin Phase 2a Study with Montelukast Versafilm(TM) in Mild to Moderate Alzheimer's Disease

SAINT-LAURENT, QUEBEC--(Marketwired - Dec. 15, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") is pleased to announce that Health Canada has cleared...
December 11, 2017 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives USPTO Notice of Allowance for Montelukast Orange Book Eligible Patent

SAINT-LAURENT, QUEBEC--(Marketwired - Dec. 11, 2017) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) ("IntelGenx"), a leading oral drug delivery company primarily focused on the...